Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00906750 · ClinicalTrials.gov registry record · Phase 1
A Study of a Live Intranasal Influenza Vaccine in Children With Cancer
A Phase 1 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00906750 is a Phase 1 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 56 participants.
The verdict
NCT00906750, a Phase 1 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
Eligible research subjects will be randomized to receive either FluMist or inactivated influenza vaccine then stratified by age and necessity to receive either one or two immunizations. Subjects requiring one immunization will be immunized at Day 0. Subjects requiring two immunizations will be immunized at Day 0 and Day 28. Subjects will be observed for 30 minutes following vaccination and given a diary card to record symptoms after each vaccination.
Interventions
- BIOLOGICAL FluMist
- BIOLOGICAL Inactivated influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00906750
The ClinicalTrials.gov registry entry for NCT00906750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FluMist is the first listed.
NCT00906750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00906750 about?
NCT00906750 is a clinical study titled "A Study of a Live Intranasal Influenza Vaccine in Children With Cancer". Eligible research subjects will be randomized to receive either FluMist or inactivated influenza vaccine then stratified by age and necessity to receive either one or two immunizations. Subjects requiring one immunization will be immunized at Day 0. Subjects requiring two immunizations will be immun...
What is the current status of trial NCT00906750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2008-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00906750?
The interventions under investigation include: FluMist (BIOLOGICAL), Inactivated influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00906750?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.